Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
J Hosp Infect ; 99(1): 75-80, 2018 May.
Article in English | MEDLINE | ID: mdl-29128347

ABSTRACT

BACKGROUND: Approximately 19% of morbidity in peripheral vascular surgery is attributable to wound complications, which can result in delayed healing, and also arterial or graft infection leading to limb loss and even mortality in extreme cases. AIM: To determine whether groin wound complications were reduced following the routine introduction of PICO negative pressure wound therapy dressings in patients who underwent peripheral vascular surgery. METHODS: Patients who underwent peripheral vascular surgery from 2011 to 2016 were identified and divided into PICO and non-PICO groups. Patient, procedure and wound characteristics were tabulated and analysed. Patients were followed-up for at least six weeks postoperatively. Wound complication rates, infection confirmed by microbiology, and requirement for re-admission due to wound complications were noted. Basic cost analysis was performed. FINDINGS: In total, 151 patients were analysed (N = 73 PICO, N = 78 non-PICO). No difference in age (P = 0.862), body mass index (P = 0.673), diabetes (P = 0.339), pre-operative albumin (P = 0.196), use of drain (P = 0.343) and history of meticillin-resistant Staphylococcus aureus (P = 0.281) was observed between groups. The PICO group contained more smokers than the non-PICO group (45% vs 29%, P = 0.034). Wound complications were seen in 8% (N = 6) of the PICO group and 19% (N = 15) of the non-PICO group (P = 0.042). No significant difference in infection was found between the two groups (3% vs 6%, P = 0.249), but fewer seromas were observed when PICO dressings were used (1.4% vs 7.7%, P = 0.069). Haematoma (2.7% vs 3.8%, P = 0.531) and dehiscence rates (1.4% vs 1.3%, P = 0.735) were similar between the two groups. CONCLUSIONS: Routine use of PICO dressings is associated with a reduction in wound complication rates following peripheral vascular surgery, and is cost-effective.


Subject(s)
Groin/surgery , Negative-Pressure Wound Therapy , Surgical Wound Infection/prevention & control , Vascular Surgical Procedures/adverse effects , Adult , Aged , Aged, 80 and over , Costs and Cost Analysis , Female , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
2.
J Surg Case Rep ; 2015(6)2015 Jun 12.
Article in English | MEDLINE | ID: mdl-26070479

ABSTRACT

A 72-year-old man presented with a 3-day history of recurrent transient ischaemic attacks comprising slurred speech, left arm weakness and paresthesia. Carotid Doppler revealed total occlusion of the right internal carotid artery (ICA). Computed tomography angiography demonstrated occlusion of the proximal right ICA over a length of 1.5 cm. The ICA distal to the occlusion was entirely normal. In view of the normal distal ICA, a decision was made to proceed with surgical exploration and right carotid endarterectomy, on the basis that there must have been some flow through the lesion. Intra-operatively, there was an extensive plaque in the carotid bulb and proximal ICA causing 80-90% stenosis. Fresh thrombus completed the occlusion. An aberrant branch of the ICA was identified distal to the plaque, the backflow through which maintained patency of the distal ICA. A standard endarterectomy was performed. The patient recovered uneventfully, being discharged on the second post-operative day.

3.
Oncol Rep ; 14(1): 235-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15944795

ABSTRACT

The plasminogen activator (PA) system comprises the 2 serine proteases, urokinase PA (uPA) and tissue PA (tPA), the 2 serpin inhibitors, PAI-1 and PAI-2 and the uPA receptor (uPAR; CD87). High levels of uPA, PAI-1, uPA-PAI-1 complex and uPAR in breast cancer tissue are associated with poor prognosis, while high levels of tPA or PAI-2 correlate with good prognosis. In this study, pre-operative plasma levels of uPA, PAI-1, uPAR, tPA, uPA-PAI-1 complex, and tPA-PAI-1 complex were measured in patients with benign (n=103) and malignant breast disease (n=113) by immunoenzymatic assays (ELISA). While plasma antigen levels of uPA, PAI-1, uPA-PAI-1 complex and uPAR were not significantly different in the 2 groups, antigen levels of tPA and tPA-PAI-1 complex were significantly higher in patients with breast carcinoma compared to the control group. In plasma from the breast cancer patients, uPA levels correlated weakly but significantly with those of tPA (r=0.20, p=0.035) and uPAR (r=0.208, p=0.028). tPA levels correlated strongly with tPA-PAI-1 complex (r=0.972, p=0.0001) while uPA-PAI-1 levels were significantly associated with PAI-1 levels (r=0.534, p<0.0001), tPA levels (r=0.348, p=0.0003) and tPA-PAI-1 levels (r=0.356, p=0.002). However, no significant correlation was found between plasma and tumor tissue levels of uPA, PAI-1, uPA-PAI-1 complex, tPA or tPA-PAI-1. Our findings indicate that determination of these factors in plasma do not reflect their concentration in tumor tissue. Therefore, measurement of PA components in blood cannot be recommended for assessing prognosis in breast cancer.


Subject(s)
Biomarkers, Tumor/blood , Breast Neoplasms/blood , Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Plasminogen Activator Inhibitor 1/blood , Plasminogen Activator Inhibitor 1/metabolism , Prognosis , Receptors, Cell Surface/blood , Receptors, Cell Surface/metabolism , Receptors, Urokinase Plasminogen Activator , Tissue Plasminogen Activator/blood , Tissue Plasminogen Activator/metabolism , Urokinase-Type Plasminogen Activator/blood , Urokinase-Type Plasminogen Activator/metabolism
4.
Br J Cancer ; 91(7): 1308-15, 2004 Oct 04.
Article in English | MEDLINE | ID: mdl-15365563

ABSTRACT

The Ets family of transcription factors regulate expression of multiple genes involved in tumour progression. The aim of this study was to investigate the expression of Ets-1 in a large panel of human breast cancers and relate its levels to the parameters of tumour progression and metastasis. Using RT-PCR, Ets-1 mRNA was detected in 30 out of 42 (71%) fibroadenomas and 131 out of 179 (73%) primary breast carcinomas. Similarly, levels of Ets-1 mRNA were not significantly different in fibroadenomas and primary breast carcinomas. Using Western blotting, four forms of the Ets-1 protein were detected, that is, p33, p42, p51 and p52. Levels of both p51 and p52 but not p33 and p42 were present at significantly higher levels in the carcinomas compared to the fibroadenomas (for p51, P<0.007; for p52, P<0.02; Mann-Whitney U-test). Levels of p52, p51 and p33 correlated significantly with uPA protein levels (P<0.01), while only levels of p52 correlated significantly with HER-2/neu protein levels (P<0.01). Using immunohistochemistry, Ets-1 was found predominantly in tumour cells, but was also detected in some stromal cells surrounding tumour islands. We conclude that, while at the mRNA level, Ets-1 was found at similar levels in fibroadenomas and primary breast carcinomas, higher protein levels were detected in the cancers compared to the benign specimens. Since p52, p51 and p33 correlate with uPA levels, these forms of Ets-1 may play a role in breast cancer metastasis.


Subject(s)
Biomarkers, Tumor/analysis , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Carcinoma/genetics , Carcinoma/pathology , Fibroadenoma/genetics , Fibroadenoma/pathology , Neoplasm Metastasis , Proto-Oncogene Proteins/biosynthesis , Transcription Factors/biosynthesis , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Humans , Protein-Tyrosine Kinases , Proto-Oncogene Protein c-ets-1 , Proto-Oncogene Proteins c-ets , Reverse Transcriptase Polymerase Chain Reaction
5.
Dig Liver Dis ; 36(6): 392-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15248379

ABSTRACT

BACKGROUND: Both the expressions of the inducible form of cyclooxygenase-2 and the presence of bone marrow micrometastases are poor prognostic markers in patients with colorectal carcinoma. AIMS: As cyclooxygenase-2 expression in these tumours is associated with increased metastatic potential in vitro, our objectives were to determine the relationship between cyclooxygenase-2 and haematogenous spread to bone marrow. PATIENTS AND METHODS: Thirty-two patients with resection of colorectal carcinoma were evaluated (median age: 69.5 years). Bone marrow was obtained from all patients from both iliac crests before manipulation of the primary tumour. The tumours were of varying stages at diagnosis (5 Dukes' A, 14 Dukes' B, 11 Dukes' C and 2 Dukes' D). Tumour sections were stained for cyclooxygenase-2 using the avidin-biotin immunohistochemical technique. Extent of staining was graded depending on the percentage of epithelial cells staining positive for cyclooxygenase-2. Micrometastases were detected by staining contaminant cytokeratin-18 positive cells in the bone marrow aspirates by either immunohistochemical (ARAAP) or immunological (flow cytometry) methods. Fisher's exact probability test was used to calculate statistical significance. RESULTS: Cyclooxygenase-2 expression in the primary tumour was detected in 72% of the patients. Twelve (38%) patients had bone marrow micrometastases detected by either immunohistochemistry or flow cytometry. Of the 12 patients who had bone marrow micrometastases, 8 tumours demonstrated increased expression of cyclooxygenase-2 protein (66.6%). In contrast, 9 out of the 20 (45%) patients in whom micrometastases were not detected expressed increased levels of cyclooxygenase-2 (P = 0.29). When dividing the patients into subgroups of localised (Dukes' A and B) versus disseminated (Dukes' C and D) disease, there was no further association between cyclooxygenase-2 expression and bone marrow micrometastases (P = 0.179 and 1.0). CONCLUSION: In this pilot study, there was no association between cyclooxygenase-2 expression and bone marrow micrometastases in patients with otherwise localised or disseminated disease.


Subject(s)
Bone Marrow Neoplasms/enzymology , Bone Marrow Neoplasms/secondary , Colorectal Neoplasms/enzymology , Isoenzymes/biosynthesis , Prostaglandin-Endoperoxide Synthases/biosynthesis , Aged , Aged, 80 and over , Bone Marrow Neoplasms/pathology , Colorectal Neoplasms/pathology , Cyclooxygenase 2 , Epithelial Cells/enzymology , Female , Flow Cytometry , Humans , Immunoenzyme Techniques , Male , Membrane Proteins , Middle Aged , Peroxidases/biosynthesis , Pilot Projects
6.
Ir J Med Sci ; 173(3): 136-40, 2004.
Article in English | MEDLINE | ID: mdl-15693382

ABSTRACT

INTRODUCTION: Overwhelming post-splenectomy infection (OPSI) has a 50-70% mortality rate and carries a lifetime risk for the asplenic patient. Specific British guidelines have been developed to reduce its incidence. AIMS: To determine whether British guidelines were being followed in our own institution and what impact they had on overwhelming post-splenectomy infection. METHODS: Retrospective chart review of 100 splenectomies performed by Department of Surgery, Beaumont Hospital from January 1990 to January 2000. RESULTS: Twenty per cent of patients were discharged without any recommended vaccinations. Prophylactic antibiotics were not prescribed in 53% of patients. Just 12% of charts document a verbal explanation of the complications and management of asplenia to the patient. Overall septic mortality was 12%, of whom 8% died in hospital and 4% after discharge. CONCLUSION: Management of the asplenic patient has improved but is far from complete. A central register of asplenic patients and national asplenic guidelines should be established in Ireland to ensure optimum patient care.


Subject(s)
Bacterial Infections/prevention & control , Guideline Adherence , Opportunistic Infections/prevention & control , Postoperative Care/standards , Postoperative Complications/prevention & control , Splenectomy/adverse effects , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Bacterial Infections/epidemiology , Bacterial Infections/immunology , Female , Hospitals, Teaching/standards , Humans , Immunocompromised Host , Incidence , Ireland , Male , Middle Aged , Opportunistic Infections/epidemiology , Opportunistic Infections/microbiology , Postoperative Complications/epidemiology , Postoperative Complications/immunology , Practice Guidelines as Topic , Registries , Retrospective Studies , Risk Assessment , Severity of Illness Index , Sex Distribution , Splenectomy/methods , Survival Rate
8.
Ir Med J ; 94(7): 200-3, 2001.
Article in English | MEDLINE | ID: mdl-11693208

ABSTRACT

Thirty three patients with phaeochromocytomas had surgery in St. Vincent's Hospital between 1950 and 1997. 32 patients had hypertension, 32 had palpitations and 30 had excessive sweating. All patients had at least one of these cardinal symptoms. Diagnostic tests changed over this period. In the early cases the phentolamine test was used, later diagnosis was confirmed by measurement of urinary VMA and catecholamines. IVP, CT, ultrasound or MIBG scanning were used to locate the tumours. Before 1967, 3 of 17 patients died peri-operatively, 2 of these from strokes and one from pulmonary embolism. Since then, all patients have survived surgery. Four of the women had phaeochromocytomas diagnosed during pregnancy. Two of the 33 patients had tumours that were malignant, the remainder being benign. One patient has died from metastatic disease. This series illustrates the changing trends in the surgical management of phaeochromocytomas.


Subject(s)
Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/surgery , Pheochromocytoma/diagnosis , Pheochromocytoma/surgery , Adolescent , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/epidemiology , Adrenal Gland Neoplasms/metabolism , Adult , Age Distribution , Aged , Cause of Death , Child , Female , Follow-Up Studies , Humans , Hypertension/etiology , Ireland/epidemiology , Male , Middle Aged , Perioperative Care , Pheochromocytoma/complications , Pheochromocytoma/epidemiology , Pheochromocytoma/metabolism , Prognosis , Sex Distribution , Sweating , Treatment Outcome , Vanilmandelic Acid/urine
9.
Surgery ; 130(5): 788-91, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11685187

ABSTRACT

BACKGROUND: The routine use of nasogastric tubes in patients undergoing elective abdominal operation is associated with an increased incidence of postoperative fever, atelectasis, and pneumonia. Previous studies have shown that nasogastric tubes have no significant effect on the incidence of gastroesophageal reflux or on lower esophageal sphincter pressure in healthy volunteers. We hypothesized that nasogastric intubation in patients undergoing laparotomy reduces lower esophageal sphincter pressure and promotes gastroesophageal reflux in the perioperative period. METHODS: A prospective randomized case-control study was undertaken in which 15 consenting patients, admitted electively for bowel surgery, were randomized into 2 groups. Group 1 underwent nasogastric intubation after induction of anesthesia, and Group 2 did not. All patients had manometry and pH probes placed with the aid of endoscopic vision at the lower esophageal sphincter and distal esophagus, respectively. Nasogastric tubes, where present, were left on free drainage, and sphincter pressures and pH were recorded continuously during a 24-hour period. Data were analyzed with 1-way analysis of variance. RESULTS: The mean number of reflux episodes (defined as pH < 4) in the nasogastric tube group was 137 compared with a median of 8 episodes in the group managed without nasogastric tubes (P =.006). The median duration of the longest episode of reflux was 132 minutes in Group 1 and 1 minute in Group 2 (P =.001). A mean of 13.3 episodes of reflux lasted longer than 5 minutes in Group 1, with pH less than 4 for 37.4% of the 24 hours. This was in contrast to Group 2 where a mean of 0.13 episodes lasted longer than 5 minutes (P =.001) and pH less than 4 for 0.2% of total time (P =.001). The mean lower esophageal sphincter pressures were lower in Group 1. CONCLUSIONS. These findings demonstrate that patients undergoing elective laparotomy with routine nasogastric tube placement have significant gastroesophageal reflux in the perioperative period and a reduced ability to clear refluxed acid from the distal esophagus. Due to the associated risk of postoperative pulmonary complications, we recommend that nasogastric intubation be performed on a selective rather than routine basis.


Subject(s)
Gastroesophageal Reflux/etiology , Intubation, Gastrointestinal/adverse effects , Case-Control Studies , Esophagogastric Junction/physiology , Humans , Hydrogen-Ion Concentration , Laparotomy , Prospective Studies
10.
Melanoma Res ; 11(5): 517-22, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11595890

ABSTRACT

Large population-based studies have shown a significant association between melanoma and lymphoid neoplasia, particularly non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL), that is independent of any treatment received for the initial tumour. This study examines the presentation, diagnosis, treatment and progress of three patients who developed advanced melanoma concurrently with a lymphoid neoplasm (one NHL, two CLLs), in order to illustrate their association, discuss common aetiological factors and examine possible therapeutic options. As it is the melanoma rather than the lymphoid neoplasm that represents the bigger threat to overall survival, initial treatment should be targeted towards this cancer. However, because of the interplay between the diseases and the possible side-effects of the various treatments, the choice of adjuvant therapy requires careful consideration. Immunosuppression associated with chemotherapy may permit a more aggressive course for the melanoma, while locoregional radiotherapy is contraindicated following lymph node dissections. As immunotherapy is of benefit in the treatment of melanoma and has also been recently shown to be effective in the management of lymphoid neoplasia, we instituted interferon-alpha as adjuvant therapy for these patients, thereby utilizing a single agent to treat the dual pathologies. The three patients have now been followed-up for 6 months without evidence of disease recurrence or progression.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell , Lymphoma, Non-Hodgkin , Melanoma , Neoplasms, Multiple Primary , Aged , Aged, 80 and over , Chemotherapy, Adjuvant/methods , Contraindications , Disease Susceptibility , Environment , Female , Humans , Incidence , Interferon-alpha/therapeutic use , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Lymph Nodes/pathology , Lymphoma, Non-Hodgkin/genetics , Lymphoma, Non-Hodgkin/immunology , Lymphoma, Non-Hodgkin/pathology , Lymphoma, Non-Hodgkin/therapy , Male , Melanoma/genetics , Melanoma/immunology , Melanoma/pathology , Melanoma/therapy , Middle Aged , Neoplasms, Multiple Primary/genetics , Neoplasms, Multiple Primary/immunology , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/therapy , Radiotherapy , Risk Factors , Ultraviolet Rays/adverse effects
13.
Br J Surg ; 88(1): 114-7, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11136322

ABSTRACT

BACKGROUND: Axillary clearance, despite its morbidity, retains an essential role in the management of patients with breast cancer. The aim of this prospective study was to document the development of arm swelling and limitation of shoulder movement following complete axillary clearance. METHODS: One hundred patients who had axillary clearance to level III, for treatment of breast cancer, were followed prospectively for over 1 year. Arm volumes were measured using an optoelectronic volometer and shoulder movements with a goniometer. RESULTS: Ten patients had significant arm swelling at 1 year. The swelling was mild in eight and moderate in two. No patient developed severe swelling. Reduced arm movements were noted in the first week after operation but had returned to normal at 6 months. CONCLUSION: This study provided accurate documentation of the morbidity associated with axillary clearance, together with a reproducible method of arm volume measurement.


Subject(s)
Breast Neoplasms/surgery , Lymph Node Excision/adverse effects , Adult , Aged , Axilla , Breast Neoplasms/pathology , Female , Humans , Lymphatic Metastasis , Lymphedema/etiology , Lymphedema/pathology , Mastectomy/methods , Middle Aged , Prospective Studies , Range of Motion, Articular
14.
Ir J Med Sci ; 170(3): 169-71, 2001.
Article in English | MEDLINE | ID: mdl-12120967

ABSTRACT

BACKGROUND: Investigation of lower extremity pain is compromised by comorbid disorders that may interfere with conventional testing. AIMS: To compare pedal ergometry with conventional treadmill testing. METHODS: A prospective study was performed where patients presenting with a diagnosis of intermittent claudication were assessed by both methods of testing. RESULTS: Of 78 patients studied with both tests, no exercise-induced ankle pressure changes occurred in 26, two were unable to complete either test despite normal pressure measurements, while 24 had exercise-induced pressure drop detected by both tests. Of patients who completed pedal ergometry, 21 were unable to complete the treadmill test, 14 of whom had negative ergometry, while seven had a pressure drop detected by pedal ergometry. Three had pressure changes with pedal ergometry, but not with treadmill testing and two had pressure changes on the treadmill not reproduced by pedal ergometry. CONCLUSIONS: Pedal ergometer is more sensitive than treadmill testing in detecting arterial insufficiency, as indicated by a 20% or greater fall in ankle pressure, and more suitable in a subgroup of patients unable to tolerate conventional treadmill testing.


Subject(s)
Exercise Test/instrumentation , Intermittent Claudication/diagnosis , Blood Pressure , Equipment Design , Exercise Test/methods , Exercise Test/statistics & numerical data , Humans , Intermittent Claudication/epidemiology , Prospective Studies
15.
Ann Surg Oncol ; 8(10): 856-60, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11776503

ABSTRACT

BACKGROUND: Primary hyperparathyroidism affects 1 in 700 individuals in the United States. A single adenoma is responsible in over 85% of cases. Surgery remains the most effective treatment. This study was designed to assess the feasibility of minimally invasive radioguided parathyroidectomy (MIRP) with confirmation of excision by ex vivo radioactivity alone. METHODS: Seventy-five consecutive patients with primary hyperparathyroidism were prospectively studied. Following sestamibi scan, patients underwent unilateral neck exploration guided by a handheld gamma probe, which was also used to measure ex vivo radioactivity of excised tissue. RESULTS: The sestamibi scan was positive in 88% of the patients. A small incision (mean, 3.2+/-0.3 cm) was sufficient. Ectopic gland sites were localized in five patients with positive scans and single adenomas. Mean operative time was 48 minutes (range, 15-125 minutes), with shorter procedures after the initial 20 cases (mean, 24 vs. 72 minutes; P < .01). Radioguided parathyroidectomy was successful in 97%, with a mean follow-up of 11 months (range, 1-26 months). As noted previously, adenomatous parathyroid glands contained more than 20% of the background radioactivity. CONCLUSIONS: MIRP is a feasible alternative to bilateral dissection with the advantages of guided dissection and rapid confirmation, and may become the procedure of choice for primary hyperparathyroidism.


Subject(s)
Adenoma/surgery , Hyperparathyroidism/surgery , Parathyroidectomy/methods , Adenoma/diagnostic imaging , Adult , Aged , Aged, 80 and over , Female , Humans , Hyperparathyroidism/diagnostic imaging , Male , Middle Aged , Minimally Invasive Surgical Procedures , Prospective Studies , Radionuclide Imaging , Radiopharmaceuticals , Technetium Tc 99m Sestamibi
16.
Ann R Coll Surg Engl ; 82(5): 336-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11041034

ABSTRACT

OBJECTIVES: To explore the influence of experience and specialisation on clinical judgement by comparing accuracy in diagnosing anaemia between a consultant general surgeon, a consultant ophthalmologist and their registrars. PATIENTS AND METHODS: Conjunctival inspection of 101 patients, subsequent correlation with haemoglobin concentration. MAIN OUTCOME MEASURES: Number of correct and incorrect diagnoses of anaemia. RESULTS: 54 patients were anaemic and 47 were not. Overall accuracy in diagnosing anaemia ranged from 0.61-0.69, sensitivity 0.52-0.65 and specificity 0.62-0.83. Agreements between pairs of examiners were 0.68-0.81, with kappa values of 0.36-0.60 when adjusted for chance agreement. CONCLUSIONS: Neither experience nor specialisation significantly influenced our ability to diagnose anaemia, based on conjunctival inspection. Without critical analysis of clinical signs, we are unaware of their diagnostic limitations.


Subject(s)
Anemia/diagnosis , Clinical Competence , Conjunctival Diseases/diagnosis , Pallor/diagnosis , Anemia/complications , Conjunctival Diseases/etiology , Female , General Surgery , Humans , Ireland , Male , Medical Staff, Hospital , Observer Variation , Ophthalmology , Pallor/etiology , Physical Examination/standards
17.
Lancet ; 354(9173): 129-30, 1999 Jul 10.
Article in English | MEDLINE | ID: mdl-10408494

ABSTRACT

In a prospective study of 29 patients with clinically node-negative breast cancer, sampling of rib marrow was superior to sampling of iliac-crest marrow for detection of micrometastases. Combination of marrow micrometastatic analysis with sentinel lymph-node mapping may improve accuracy of staging in breast cancer.


Subject(s)
Bone Marrow Neoplasms/secondary , Breast Neoplasms/pathology , Lymph Nodes/pathology , Neoplasm Staging/methods , Axilla , Bone Marrow Neoplasms/pathology , Female , Humans , Ilium , Lymphatic Metastasis/diagnosis , Prospective Studies , Ribs/pathology
18.
J Med Eng Technol ; 23(2): 53-6, 1999.
Article in English | MEDLINE | ID: mdl-10356674

ABSTRACT

We use a braided polyester suture in place of cerclage wire in tension band fixations. The objective of this study was to test the biomechanical properties of this technique. Sixteen cadaveric patellae were fractured and repaired by modified tension band fixation. Eight were fixed using eighteen gauge stainless steel wire as a tension band and eight using braided polyester. All specimens were subjected to tensile testing. Polyester was 75.0% as strong as wire. For dynamic testing, the patellae of seven cadaveric knees were fractured and then fixed with polyester tension bands. These were mounted in a device capable of extending the knees from 90 degrees to neutral against an applied force. None of the fixations failed. Three of the specimens fixed using 18 gauge stainless steel wire were compared with three fixed using polyester over 2000 cycles of knee flexion and extension. Polyester performed as well as wire. We conclude that polyester is an acceptable alternative to wire in tension band fixation.


Subject(s)
Fracture Fixation, Internal/methods , Patella/surgery , Polyesters , Sutures , Biomechanical Phenomena , Bone Wires , Humans , In Vitro Techniques , Knee Joint/physiology , Movement , Patella/injuries , Stainless Steel , Suture Techniques , Tensile Strength
19.
Int J Cancer ; 84(1): 44-8, 1999 Feb 19.
Article in English | MEDLINE | ID: mdl-9988231

ABSTRACT

Studies from model systems suggest that matrix metalloproteinases (MMPs) are causally involved in tumor progression while tissue inhibitors of MMPs (TIMPs) prevent this progression. Here, we show that concentrations of TIMP-1 are significantly higher in breast carcinomas than in fibroadenomas. In primary breast cancers, TIMP-1 concentrations increased with increasing tumor size but showed an inverse relationship with estrogen receptor concentrations. In primary breast cancers also, TIMP-1 levels were weakly but significantly correlated with those for MMP-1, proMMP-2, active MMP-2, MMP-3 and proMMP-9. Contrary to what might be expected from published data on model systems, high concentrations of TIMP-1 predicted a poor outcome in patients with breast cancer. We conclude that in human breast cancer, endogenous TIMP-1 does not inhibit tumor progression but may enhance the process.


Subject(s)
Biomarkers, Tumor/analysis , Breast Neoplasms/metabolism , Tissue Inhibitor of Metalloproteinase-1/analysis , Breast Neoplasms/mortality , Collagenases/analysis , Collagenases/metabolism , Disease Progression , Female , Gelatinases/analysis , Humans , Matrix Metalloproteinase 1 , Matrix Metalloproteinase 2 , Matrix Metalloproteinase 3/analysis , Metalloendopeptidases/analysis , Prognosis , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...